Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT Guided Treatment vs Usual Care in Asthma
NCT02868281Phase 4Completed
- Sponsor
- GSK
- Start
- Aug 2016
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in asthma (2 arms), sponsored by GSK. Primary endpoint: Percentage of Participants Who Had an ACT Total Score >=20 or an Improvement of More Than 3 Points in ACT at 24 weeks. Started Aug 2016; status: completed.
02
Conditions
asthma
Beyond the preview
Go deeper on NCT02868281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02868281.